Search
Menu
Meadowlark Optics - SEE WHAT

TriLink BioTechnologies Inc.

Facebook X LinkedIn Email
TriLink BioTechnologies Inc. of San Diego has been awarded a Small Business Innovation Research Phase I grant of approximately $100,000. In the Phase I study, the company will investigate its second approach for Hot Start activation of polymerase chain reaction (PCR). This technique, which employs chemically modified triphosphates to inhibit DNA polymerase activity until a thermal activation step, has shown significant promise toward reducing off-target amplification products in PCR.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: July 2007
    BiophotonicsDNANews & Featuresthermal activationTriLink BioTechnologies Inc.

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.